FDA Inspection 800103 — Akesis
The FDA completed an inspection of Akesis on September 14, 2012 in Lake Wylie, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 14, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lake Wylie, SC (United States)
Additional Details
Sponsor, Contract Research Organization